Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study is designed to evaluate the efficacy and safety of eltrombopag monotherapy in Japanese adult patients with platelet transfusion-dependent lower-risk Myelodysplastic syndromes (LR-MDS).
Epistemonikos ID: 1ca0ae3bc227b8384e99cb64d61750ce49753999
First added on: May 08, 2024